Physician
Internal Medicine
Dr. Edward Rubenstein, MD
|
|
Give Review
Edward Rubenstein works in the field of Internal Medicine. He went to University Hospital - University of Cincinnati College of Medicine. He over the years received 1 awards: "Elected Member". Edward Rubenstein is a published doctor and has 55 publications published. The lastest was: 'Mississippi mud in the 1990s: risks and outcomes of vancomycin-associated toxicity in general oncology practice.'
Publications
- New approaches to chemotherapy-induced nausea and vomiting: from neuropharmacology to clinical investigations.
- Role of prophylactic quinolones in reducing febrile neutropenia in patients undergoing myelosuppressive chemotherapy.
- Incidence of chemotherapy-induced nausea and emesis after modern antiemetics.
- Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
- Evidence-based guidelines for managing mucositis.
- The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis.
- Measuring chemotherapy-induced nausea and emesis.
- Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin-11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy.
- Patient preferences regarding side effects of chemotherapy for ovarian cancer: do they change over time?
- The Bleeding Risk Index: a clinical prediction rule to guide the prophylactic use of platelet transfusions in patients with lymphoma or solid tumors.
- Pathogenesis of trehalose dimycolate-induced interstitial pneumonitis. IV. Evidence against roles for immunoglobulins and the complement system.
- Fever in patients with neutropenia.
- Methodology for clinical trials involving patients with cancer who have febrile neutropenia: updated guidelines of the Immunocompromised Host Society/Multinational Ass...
- Current management of disseminated intravascular coagulation.
- Hyperbilirubinemia after single-stage radical cystectomy and ileal loop diversion.
- Outpatient treatment of febrile neutropenic patients with cancer.
- Ciprofloxacin-induced nephrotoxicity in patients with cancer.
- Colony stimulating factors in patients with fever and neutropenia.
- Outpatient antibiotic therapy for febrile episodes in low-risk neutropenic patients with cancer.
- NCCN: Fever and neutropenia.
- Early empiric antibiotic therapy for febrile neutropenia patients at low risk.
- ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study.
- Outpatient antibiotic therapy in febrile neutropenic patients undergoing high-dose chemotherapy and autologous bone marrow support.
- Evaluating cost-effectiveness in outpatient management of medical complications in cancer patients.
- Oral antibiotics for febrile patients with neutropenia due to cancer chemotherapy.
- Vascular access by physician assistants: evaluation of an implantable peripheral port system in cancer patients.
- The electronic medical record in a research institution: competing constituencies in a publish or perish world.
- Three palonosetron regimens to prevent CINV in myeloma patients receiving multiple-day high-dose melphalan and hematopoietic stem cell transplantation.
- Outpatient antibiotic treatment in low-risk febrile neutropenic cancer patients.
- Costs and benefits of outpatient therapy.
- Costs of blood transfusion: a process-flow analysis.
- Time to clinical response: an outcome of antibiotic therapy of febrile neutropenia with implications for quality and cost of care.
- Re-examination of clinical aspects of pharmacoeconomic analysis.
- The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.
- Incorporating new modalities into practice guidelines: platelet growth factors.
- Pharmacoeconomic analyses: whose perspective counts and costs the most?
- Influence of data display formats on physician investigators'' decisions to stop clinical trials: prospective trial with repeated measures.
- Incidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopenia.
- Medical futility and appropriate medical care in patients whose death is thought to be imminent.
- Controversies in new antibiotic therapy for ambulatory patients.
- Identifying risk factors for imminent death in cancer patients with acute dyspnea.
- Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor.
- Outpatient management of febrile episodes in neutropenic cancer patients.
- Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials.
- Dyspnea in cancer patients. Etiology, resource utilization, and survival-implications in a managed care world.
- Randomized, double blind, dose-response trial across four oral doses of dolasetron for the prevention of acute emesis after moderately emetogenic chemotherapy. Oral Do...
- Mississippi mud in the 1990s: risks and outcomes of vancomycin-associated toxicity in general oncology practice.
- Ambulatory management of varicella-zoster virus infection in immunocompromised cancer patients.
- Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer.
- Nature and outcome of febrile episodes in patients with pancreatic and hepatobiliary cancer.
- Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis.
- Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients.
- Palonosetron triggers 5-HT(3) receptor internalization and causes prolonged inhibition of receptor function.
- Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer.
Schools
University of Cincinnati Main Campus
Cincinnati Genl Hospital
Barnes Jewish Hospital
May Institute
Doctors Specialties
- Internal Medicine
Accepted Insurances
Awards
- Elected Member
Education
-
Washington University - Barnes-Jewish Hospital -
University Hospital - University of Cincinnati College of Medicine -
University of Cincinnati College of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Preetha Basaviah, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Irine Vodkin, MD |
|
|
Dr. Mark R. Cullen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Margaret McKinney, MD |
|
|
Dr. Jason L. Hom, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen Pan, MD |
|
|
Iain R. McDougall, MB CHB
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Celina M. Yong, MD
This Doctor is OpenDoctor Recommended.
|